Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Epizyme parts ways with its CEO ahead of big Phase II cancer bet
Epizyme parts ways with its CEO ahead of big Phase II cancer bet
Epizyme parts ways with its CEO ahead of big Phase II cancer bet
Submitted by
admin
on August 7, 2015 - 10:41am
Source:
Fierce Biotech
News Tags:
Epizyme
Robert Gould
blood cancers
Headline:
Epizyme parts ways with its CEO ahead of big Phase II cancer bet
Do Not Allow Advertisers to Use My Personal information
